Azelastine & Fluticasone Nasal Spray

Azelastine & Fluticasone Nasal Spray
Product Description

Read more Show less

Sava Healthcare Ltd

  • IN
  • 2019
    On CPHI since
  • 2
    Certificates
  • 500 - 999
    Employees
Company types
CMO/CDMO
Pharmaceutical company
Veterinary Company
Primary activities
Contract Manufacturer
Out-licensing specialist
Pharmaceutical Company (generic finished products)
View company profile

Sava Healthcare Ltd

  • IN
  • 2019
    On CPHI since
  • 2
    Certificates
  • 500 - 999
    Employees
Company types
CMO/CDMO
Pharmaceutical company
Veterinary Company
Primary activities
Contract Manufacturer
Out-licensing specialist
Pharmaceutical Company (generic finished products)
View company profile

More Products from Sava Healthcare Ltd (1)

Sava Healthcare Ltd resources (1)

  • News SAVA Healthcare to set up second manufacturing plant in Indore

    SAVA Healthcare conducted the ground-breaking ceremony of its second manufacturing plant, in the Smart Industrial Park (SIP) of Madhya Pradesh Industry Development Corporation (MPIDC) in March.

    SAVA Healthcare currently operates a Health Canada, PIC/s approved facility in Gujarat’s Surendranagar and an R&D centre in Pune.

    The proposed second plant will have a projected annual production capacity of 2,351.3 million SKUs which will include tablets, capsules, dry powder for oral suspension, ointments, nasal sprays, and dry powders for inhalation.

    Situated on 13.8 acres of prime land, the forthcoming facility will reportedly meet stringent regulatory standards such as EUGMP / USFDA of global pharma markets.
    15 Apr 2024